Barreto, A.R.R.; Valente, A.P.C.; Schaeffer, E.; de Almeida, V.M.; Muzitano, M.F.; Barth, T.; de Souza, A.M.T.; de A. A. Vieira, B.; da Silva, A.M.; Santos-Filho, O.A.;
et al. Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx. Pharmaceutics 2026, 18, 664.
https://doi.org/10.3390/pharmaceutics18060664
AMA Style
Barreto ARR, Valente APC, Schaeffer E, de Almeida VM, Muzitano MF, Barth T, de Souza AMT, de A. A. Vieira B, da Silva AM, Santos-Filho OA,
et al. Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx. Pharmaceutics. 2026; 18(6):664.
https://doi.org/10.3390/pharmaceutics18060664
Chicago/Turabian Style
Barreto, Arielly R. R., Ana Paula C. Valente, Edgar Schaeffer, Vitor M. de Almeida, Michelle F. Muzitano, Thiago Barth, Alessandra M. T. de Souza, Bárbara de A. A. Vieira, Alcides Monteiro da Silva, Osvaldo A. Santos-Filho,
and et al. 2026. "Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx" Pharmaceutics 18, no. 6: 664.
https://doi.org/10.3390/pharmaceutics18060664
APA Style
Barreto, A. R. R., Valente, A. P. C., Schaeffer, E., de Almeida, V. M., Muzitano, M. F., Barth, T., de Souza, A. M. T., de A. A. Vieira, B., da Silva, A. M., Santos-Filho, O. A., Steel, P. G., & Rossi-Bergmann, B.
(2026). Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx. Pharmaceutics, 18(6), 664.
https://doi.org/10.3390/pharmaceutics18060664
